Hot Pursuit     11-Nov-24
Aurobindo Pharma Ltd drops for fifth straight session
Aurobindo Pharma Ltd is quoting at Rs 1265.85, down 4.65% on the day as on 12:59 IST on the NSE. The stock jumped 29.25% in last one year as compared to a 24.11% rally in NIFTY and a 43.47% spurt in the Nifty Pharma index.

Aurobindo Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 1265.85, down 4.65% on the day as on 12:59 IST on the NSE. The benchmark NIFTY is up around 0.35% on the day, quoting at 24233.2. The Sensex is at 79752.86, up 0.34%.Aurobindo Pharma Ltd has eased around 15% in last one month.Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has eased around 5.71% in last one month and is currently quoting at 22542.25, down 0.95% on the day. The volume in the stock stood at 23.08 lakh shares today, compared to the daily average of 8.02 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 1269.35, down 4.92% on the day. Aurobindo Pharma Ltd jumped 29.25% in last one year as compared to a 24.11% rally in NIFTY and a 43.47% spurt in the Nifty Pharma index.

The PE of the stock is 40.7 based on TTM earnings ending June 24.

Previous News
  Aurobindo Pharma announces board meeting date
 ( Corporate News - 17-May-25   16:08 )
  Aurobindo Pharma Ltd Slips 3.92%, BSE Healthcare index Shed 1.06%
 ( Hot Pursuit - 06-May-25   09:30 )
  Aurobindo Pharma drops after fire incident at Kakinada facility
 ( Hot Pursuit - 29-Apr-25   16:22 )
  CuraTeQ Biologics s.r.o. receives positive opinion for biosimilar Dazublys® from EMA
 ( Corporate News - 26-Apr-25   13:58 )
  Aurobindo Pharma rallies after arm receives USFDA nod for Dasatinib tablets
 ( Hot Pursuit - 23-Apr-25   12:05 )
  Aurobindo Pharma rallies after receiving USFDA nod for Rivaroxaban tablets
 ( Hot Pursuit - 15-Apr-25   10:07 )
  Aurobindo Pharma gets USFDA nod for Rivaroxaban tablets
 ( Hot Pursuit - 14-Apr-25   08:59 )
  USFDA inspects Aurobindo Pharma's Raleigh Plant in North Carolina
 ( Corporate News - 11-Apr-25   15:22 )
  CuraTeQ Biologics completes Phase 1 study of denosumab biosimilar, BP16
 ( Corporate News - 09-Apr-25   20:47 )
  Aurobindo Pharma’s arm receives permission from European Commission to market Dyrupeg
 ( Hot Pursuit - 07-Apr-25   12:54 )
  Volumes spurt at Aurobindo Pharma Ltd counter
 ( Hot Pursuit - 03-Apr-25   11:00 )
Other Stories
  NSE SME IPO of Dar Credit & Capital subscribed 5.35 times
  21-May-25   17:11
  Trident spurts after Q4 PAT climbs 135% YoY to Rs 133 cr
  21-May-25   16:00
  Torrent Pharma gains as Q4 PAT rises 11% YoY to Rs 498 cr; recommends final dividend of Rs 6/sh
  21-May-25   15:26
  J. Kumar Infra gains after Q4 PAT rises 15% YoY to Rs 114 cr
  21-May-25   15:09
  Fineotex Chemical Ltd leads losers in 'A' group
  21-May-25   15:00
  Music Broadcast Ltd leads losers in 'B' group
  21-May-25   14:45
  Power & Instrumentation (Gujarat) surges on fresh order win
  21-May-25   14:41
  Volumes soar at JK Tyre & Industries Ltd counter
  21-May-25   14:30
  United Spirits Q4 PAT rises 17% YoY; recommends final dividend of Rs 8/sh
  21-May-25   14:27
  Consumer Durables shares fall
  21-May-25   14:00
Back Top